¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"organ tolerance dose"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
¿µ¹® dose ÇÑ±Û ¿ë·®, Åõ¿©·®, ¹æ»ç¼±·®
¼³¸í   
  1. ¾àÁ¦¸¦ ÇÑ ¹ø ¶Ç´Â ÇÏ·ç¿¡ »ç¿ëÇϰųª º¹¿ëÇϴ ºÐ·®. 2. ¹°ÁúÀ̳ª Á¶Á÷¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ÀÛ¿ë Á¤µµ¸¦ ³ªÅ¸³»´Â ¾ç. Áï, ¹æ»ç¼±·®À̶ó´Â °³³äÀº ¾î¶² ÇÑ Á¡¿¡ ÀÔ»çÇϴ ¹æ»ç¼±°ú ±× Á¡ ±Ùó¿¡ Àִ ¹°Áú¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ¹°¸®Àû-È­ÇÐÀû-»ý¹°ÇÐÀû È¿°ú¿ÍÀÇ °ü°Ô¸¦ Á¤·®ÀûÀ¸·Î ³ªÅ¸³»´Â °øÅëÀΠôµµ·Î¼­ »ý°¢µÈ °ÍÀÌ´Ù. ¶óµå(rad)·Î ³ªÅ¸³»´Â Èí¼ö·®, ·»Æ®°Õ(R)À¸·Î ³ªÅ¸³»´Â Á¶»ç ¼±·®, ·½(rem)À¸·Î ³ªÅ¸³»´Â ¼±·® ´ç·®À¸·Î ±¸ºÐÇÏ¿© ¾´´Ù.
¿µ¹® organ of Corti ÇÑ±Û ÄÚ¸£Æ¼±â°ü
¼³¸í   
  À½ÀÇ Áøµ¿À» Àü±âÀû ½ÅÈ£·Î ¹Ù²Ù¾î ´ë³ú°¡ ´À³¥ ¼ö ÀÖµµ·Ï ÇØÁØ´Ù. À§Ä¡´Â ¼Ó±Í¿¡ ÀÖÀ¸¸ç, ¼Ó±Í¾È¿¡ Àִ ´ÞÆØÀ̰ü¿¡ Á¸ÀçÇÑ´Ù.
  
  ÄÚ¸£Æ¼±â°ü
¿µ¹® skin dose ÇÑ±Û ÇǺμ±·®
¼³¸í   
  1. ÇǺÎÇ¥¸é¿¡¼­ÀÇ ¹æ»ç¼±ÀÇ °øÁß¼±·®À¸·Î ¿©±â¿¡´Â 1Â÷¹æ»ç¼±°ú ÈĹæ»ê¶õÀÌ Æ÷ÇԵȴÙ. 2. ÇǺο¡ Èí¼öµÇ´Â ¼±·®.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • self-tolerance
    1. ÀÚ°¡°ü¿ë 2. ÀÚ°¡³»¼º
  • artificial organ
    ÀΰøÀå±â
  • circumventricular organ
    ³ú½ÇÁÖÀ§±â°ü
  • critical organ
    À§ÇèÀå±â
  • central lymphoid organ
    ÁßÃ߸²ÇÁ±â°ü
  • digestive organ
    ¼ÒÈ­±â°ü
  • excretory organ
    ¹è¼³±â°ü
  • external genital organ
    ¹Ù±ù»ý½Ä±â°ü, ¿ÜºÎ»ý½Ä±â°ü
  • extranodal organ
    ¸²ÇÁÀý¿ÜÀå±â
  • extraperitoneal organ
    º¹¸·¿Ü±â°ü, ¹è¸·¹Ù±ù±â°ü
  • effector organ
    È¿°ú±â°ü
  • embryonic organ
    ¹è¾Æ±â°ü
  • enamel organ
    ¿¡³ª¸á±â°ü
  • end organ
    Á¾¸»±â°ü
  • end organ deafness
    Á¾¸»±â°ü³­Ã»
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
  • organ culture
    Àå±â¹è¾ç
  • organ donor
    Àå±âÁ¦°øÀÚ, Àå±âÁÖ´ÂÀÌ
  • organ
    ±â°ü, Àå±â
  • artificial organ
    Àΰø±â°ü, ÀΰøÀå±â
  • end organ
    Á¾¸»±â°ü
  • extranodal organ
    ¸²ÇÁÀýÀÌ¿ÜÀå±â
  • reproductive organ
    »ý½Ä±â°ü
  • respiratory organ
    È£Èí±â°ü
  • sensory organ
    °¨°¢±â°ü
  • solid organ
    ½ÇÁú±â°ü, ½ÇÁúÀå±â, °íÇüÀå±â
  • spiral organ
    ³ª¼±±â°ü
  • static organ
    ÆòÇü±â°ü
  • subfornical organ
    ³úȰ¹Ø±â°ü
  • target organ
    Ç¥ÀûÀå±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heat tolerance
    ³»¿­¼º
  • heparin tolerance test
    ÇìÆÄ¸°³»¼º°Ë»ç
  • high-zone tolerance
    Ç׿ø°ú·®Çã¿ë
  • immunologic tolerance
    ¸é¿ª°ü¿ë
  • induction tolerance
    ¸é¿ª°ü¿ëÀ¯¹ß
  • low-zone tolerance
    Ç׿ø¼Ò·®Çã¿ë
  • median tolerance limit
    ¹Ý¼ö»ýÁ¸ÇѰè³óµµ
  • metabolic tolerance
    ´ë»ç³»¼º
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • pharmacodynamic tolerance
    ¾à¿ªÇг»¼º
  • pressure tolerance
    ¾Ð¹Ú³»¼º
  • self-tolerance
    ÀÚ°¡°ü¿ë¼º
  • self tolerance
    ÀÚ±â¸é¿ªÇã¿ë
  • sitting tolerance
    ÁÂÀ§³»¼º, ¾ÉÀ½³»¼º
  • split tolerance
    ºÐÇҸ鿪Çã¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gustatory organ =taste o.
    ¹Ì°¢±â°ü, ¹Ì±â(°ü)(Ú«Ðïη).
  • haemopoietic organ
    Ç÷¾×Çü¼º±â°ü
  • hallucination of organ See h., cenesthetic
    Àå±âȯ°¢(íôÐïü³ÊÆ)
  • hearing organ
    û°¢±â°ü(ôéÊÆÐïί).
  • hearing organ
    û°¢±â°ü
  • hemopoietic organ
    Ç÷__ü¼º±â°__ Á¶Ç÷±â°ü.
  • hemopoietic organ
    Ç÷±¸Çü¼º±â°ü, Á¶Ç÷±â°ü.
  • hollow organ
    ¼ÓºóÀå±â, Áß°ø±â°ü(ñéÍöÐïί), Áß°øÀå±â(ñéÍöíôÐï).
  • phonatory organ
    ¹ß¼º±â(Û¡á¢Ðï).
  • phonatory organ
    ¹ß¼º±â
  • receptor organ
    ¼ö¿ë±â°ü(áôé»Ðïί).
  • GTT= glucose tolerance test
    ´çºÎÇÏ °Ë»ç.
  • Glucose tolerance
    ³»´ç·Â(Ò±ÓØÕô)
  • Gudmand-Hoyer lactose tolerance test
    ±¸µÎ¸¸-È£À̾î À¯´çºÎÇϽÃÇè
  • acceleration tolerance
    °¡¼Ó³»¼º(Ê¥áÜ Ò±àõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cumulative dose ; cumulate dose
    ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® .[¿¹¹æ]ÁýÀû¼±·®.
  • dose rate ; dosage rate ; dose per unit time
    ¹æ»ç ÀÓº´,ÇÙÀÇ,¾à¸®¼±·®·ü, ¿ë·®.
  • optimal dose ; optimum dose
    ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
  • optimal dose ; optimum dose
    ¹æ»ç [¾à¸®,ÇØºÎ,¿¹¹æ]ÃÖÀû·®, ÀûÁ¤·®(ËøËøËâ).
  • optimal dose ; optimum dose
    ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
  • acceleration tolerance
    °¡¼Ó³»¼º(Ê¥áÜ Ò±àõ)
  • acquired tolerance
    ȹµæ°ü¿ë, ÈÄõ¼º°ü¿ë
  • acquired tolerance
    ÈÄõ(¼º) ³»¼º(¡­Ò±àõ), ȹµæ°ü¿ë.
  • adoptive tolerance
    ÀÔ¾ç(¸é¿ª)°ü¿ë(ìýåרóæ¹Î°é»).
  • alcohol tolerance
    ¾ËÄڿ󻼺(¡­Ò±àõ).
  • alkali tolerance
    ¾ËÄ®¸®³»¼º(¡­Ò±àõ)
  • altimeter tolerance
    ³»°í¼Ò¼º(ËÀË­ËÛËÛ).
  • antigen tolerance
    Ç׿ø°ü¿ë.
  • autoimmune disease,immunologic tolerance
    ¸é¿ª°ü¿ë(Øóæ¹Î°é»)
  • autoimmune disease,tolerance
    ³»¿ë·Â(Ò®é»æ³)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Enamel organ
    »ç±âÁú±â°ü
    [¿¾ ¿ë¾î] ¿¡³ª¸á±â
  • Enamel organ
    »ç±âÁú±â°ü
    [¿¾ ¿ë¾î] ¿¡³ª¸á±â°ü
  • VISUAL ORGAN
    ½Ã°¢±â°ü
    [¿¾ ¿ë¾î] ½Ã°¢±â
  • Neurotendinal spindle [Golgi tendon organ]
    ½Å°æÈûÁÙ¹æÃß
    [¿¾ ¿ë¾î] ½Å°æ°Ç¹æÃß
  • EXTERNAL GENITAL ORGAN OF FEMALE
    ¿©¼º¹Ù±ù»ý½Ä±â°ü
    [¿¾ ¿ë¾î] ¿©¼º¿Ü»ý½Ä±â
  • Total organ duplication (Double ureter)
    Àüü±â°üÁߺ¹ (°ã¿ä°ü)
    [¿¾ ¿ë¾î] Àüü±â°üÁߺ¹ (°ã¿ä°ü)
  • VESTIBULOCOCHLEAR ORGAN
    ÆòÇüû°¢±â°ü
    [¿¾ ¿ë¾î] ÆòÇüû°¢±â
  • OLFACTORY ORGAN
    Èİ¢±â°ü
    [¿¾ ¿ë¾î] Èİ¢±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • tolerance
    ³»¼º (Ò±àõ)
  • transferred tolerance
    ÀüÀÌ ³»¼º(ï®ì¹Ò±àõ)
  • absorbed dose
    Èí¼ö·® (ýåâ¥Õá)
  • air dose
    ´ë±â¼±·®(ÓÞѨàÊÕá)
  • booster dose
    ºÎ½ºÅÍ ·®(Õá)
  • dose-response curve
    ¿ë·®´ëÀÀ °î¼±(é»ÕáÓßëëÍØàÊ)
  • exposure dose
    ³ëÃâ·®(ÖÚõóÕá)
  • fractionated dose
    ºÐÇÒ·®(ÝÂùÜÕá)
  • half-value dose
    ¹Ý(Úâ)°ª ¼±·®(àÊÕá)
  • lethal dose
    Ä¡»ç·®(öÈÞÝÕá)
  • maximum permissible dose
    ÃÖ´ëÇã¿ë·®(õÌÓÞúÉé»Õá)
  • median effective dose
    Á¤Áß À¯È¿·®(ïáñéêóüùÕá)
  • median hemolytic dose
    Á¤Áß ¿ëÇü·®(ïáñééÁúìÕá)
  • median immunizing dose
    Á¤Áß ¸é¿ª·®(ïáñéØóæµÕá)
  • median infectious dose
    Á¤Áß °¨¿°·®(ïáñéÊïæøÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • median lethal dose
    50%Ä¡»ç·®, Æò±ÕÄ¡»ç·®
  • midbreast dose
    À¯¹æÁß¾ÓÁ¶»ç¼±·®
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • permissible internal dose
    ³»ºÎÇã¿ë¼±·®
  • radiation absorbed dose
    ¶óµå, ¹æ»ç¼±Èí¼ö¼±·®
  • relative dose
    ºñ±³Á¶»ç·®, »ó´ëÁ¶»ç·®
  • single dose
    ÀÏȸ·®
  • skin dose
    ÇǺμ±·®
  • critical organ
    Ç¥ÀûÀå±â, À§ÇØÀå±â
  • female genital organ
    ¿©ÀÚ»ý½Ä±â, ¿©¼º¼º±â
  • male genital organ
    ³²ÀÚÀÇ »ý½Ä±â, ³²¼º¼º±â
  • male organ
    ³²¼º±â°ü, ¼ö±â°ü, ¿õ¼º±â
  • olfactory organ
    Èİ¢±â°ü
  • organ
    Àå±â, ±â°ü, ±â
  • organ transplantation
    Àå±âÀ̽Ä
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ETT endotracheal tube; epinephrine tolerance test; exercise tolerance test; exercise treadmill test; ext...
LTT lactose tolerance test; leucine tolerance test; limited treadmill test; lymphocyte transformation te...
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
LD labor and delivery; laboratory data; labyrinthine defect; lactate dehydrogenase; laser Doppler; lear...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GTT Glucose Tolerance Test
GT Glucose tolerance
IVGTT I.v. glucose tolerance tests
ITI Immune tolerance induction
IGT Impaired Glucose Tolerance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pain tolerance
    µ¿Åë ³»¼º, ÅëÁõ ³»¼º
    ÂüÀ» ¼ö ÀÖ´Â ÅëÁõÀÇ °¡Àå Å« ¼öÁØ.
  • pharmacodynamic tolerance
    ¾à¿ªÇÐÀû ³»¼º
  • poison tolerance
    µ¶¹° ³»¼º
    Áö¼ÓÀûÀÎ µ¶¼º ¹°Áú¿¡ ÀÇÇØ »ýü°¡ ±× µ¶¼º ¹°Áú¿¡ ÀúÇ×¼ºÀ» ³ªÅ¸³»´Â °Í.
  • tolerance
    ³»¾à¼º, ³»¼º, ³»¿ë·Â, Çã¿ë, °ü¿ë
    1. º¸Åë ¾à¹°À̳ª µ¶¹°ÀÇ ¸¹Àº »ç¿ë·®À» °ßµð¾î ³¾ ¼ö ÀÖ´Â ´É·Â. 2. ÈÄõÀûÀ¸·Î ȹµæµÈ ¾à¹° ³»¼º. ¹Ýº¹ÀûÀÎ µ¿·®ÀÇ »ç¿ë·®¿¡ ´ëÇÑ ¹ÝÀÀ¼ºÀÇ °¨¼Ò ȤÀº °°Àº ¹ÝÀÀÀ» ¾ò±â À§Çؼ­ Áõ°¡µÈ »ç¿ë·®À» ¿ä±¸ÇÏ´Â °Í.
  • tolerance span
    Àγ» ±â°£
  • tolerance to antimicrobial
    Ç×±ÕÁ¦ ³»¼º
  • tolerance to high altitude
    °í¼Ò ³»¼º
  • abdominal organ
    º¹ºÎ ±â°ü, º¹ºÎ Àå±â
    º¹ºÎ¿¡ Æ÷ÇÔµÈ Àå±â·Î¼­ °£, À§Àå, ¼ÒÀå, ´ëÀå, ÃéÀå, ºñÀå µîÀÌ ÀÖ´Ù.
  • abnormality of organ
    ±â°ü ÀÌ»ó
    Æó, ½ÉÀå, °£Àå, ÃéÀå, ½ÅÀå µî°ú °°Àº ±â°üÀÇ Çüųª ¼ö°¡ Á¤»óÀûÀÌÁö ¾ÊÀº »óÅÂ.
  • central lymphatic organ
    ÁßÃß ÀÓÆÄ°è ±â°ü, ÁßÃß ¸²ÇÁ Á¶Á÷ Àå±â
    Ç×ü »ý»ê ¹× ¼¼Æ÷ ¸é¿ª¿¡ °ü¿©ÇÏ´Â ¸é¿ª Á¶Á÷ Áß¿¡¼­ °£ ¼¼Æ÷·ÎºÎÅÍ ¸é¿ª Ȱ¼º ¼¼Æ÷·ÎÀÇ ºÐÈ­ÀÇ Àå¼Ò°¡ µÇ´Â ¸²ÇÁ Á¶Á÷À» ÁßÃß ¸²ÇÁ Á¶Á÷À̶ó°í ºÎ¸¥´Ù. À̰Ϳ¡´Â Èä¼±, Á¶·ù¿¡¼­´Â Fabricius³¶, Æ÷À¯·ù¿¡¼­´Â À̰Ͱú À¯»çÇÑ Á¶Á÷ÀÌ Æ÷ÇԵȴÙ.
  • critical organ
    Ç¥Àû Àå±â, À§ÇØ Àå±â, ÇѰè Àå±â
  • dental organ
    Ä¡¾Æ±â
    Ä¡¾Æ Çü¼º °úÁ¤¿¡¼­ ¹ý¶ûÁúÀ» Çü¼ºÇÏ°Ô µÉ ºÎºÐ.
  • digestive organ
    ¼ÒÈ­ ±â°ü
    µ¿¹°ÀÌ ¼·ÃëÇÑ ¿µ¾ç¼Ò¸¦ ÀúÀå, ¼ÒÈ­, Èí¼öÇÏ´Â ÀÛ¿ëÀ» °¡Áø ±â°ü. ¼ÒÈ­±â¶ó°íµµ ÇÑ´Ù. ¿ø»ýµ¿¹° Áß¿¡¼­µµ ¤½Å¹ú·¹´Â ¸öÀÇ ÀϺο¡ ¸ÔÀ̸¦ ¼·ÃëÇÏ´Â ÀÔ°ú ½Äµµ¿Í °°Àº ¼¼Æ÷ ±â°üÀ» º¼ ¼ö ÀÖÀ¸³ª, º»·¡ÀÇ ¼ÒÈ­ ±â°üÀº ÇØ¸éµ¿¹° À̻󿡼­ ¹ß´ÞµÇ¾î ÀÖ´Ù. ôÃß µ¿¹°ÀÇ ¼ÒÈ­±â°üÀÌ °¡Àå ¹ß´ÞÇÏ¿© ±¸°­, ÀÌ, Çô, ÀεÎ, ½Äµµ, À§, Àå
  • douching : a jet or current of water, sometimes a dissolved medicating or cleansing agent, applied to a body part, organ or cavity for medicinal or hygienic purposes.

    dough

    ¹ÝÁ×ÇÑ °Í, ³¯ ºÐ
  • embryonic organ
    ¹è¾Æ ±â°ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
self tolerance The normal lack of the ability to produce an immunological response to autologous (self) antigens. A breakdown of self tolerance leads to autoimmune diseases. The ability to recognise the difference between self and non-self is the prime function of the immune system.
(12 Dec 1998)
species tolerance The insensitivity to a particular drug exhibited by a particular species.
(05 Mar 2000)
split tolerance Modification of an immune response to an antigen after prior exposure to that antigen.
Synonym: split tolerance.
(05 Mar 2000)
nonresponder tolerance Lack of immune response to antigen. Theories of tolerance induction include clonal deletion and clonal anergy. In clonal deletion, the actual clone of cells is eliminated whereas in clonal anergy the cells are present but nonfunctional.
Synonym: immunological tolerance, immunotolerance, nonresponder tolerance.
(05 Mar 2000)
drug tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from drug resistance wherein a human, animal, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug.
(12 Dec 1998)
immune tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (foetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
(12 Dec 1998)
immunological tolerance <immunology> Specific unresponsiveness to antigen. Self tolerance is a process occurring normally early in life due to suppression of self reactive lymphocyte clones.
Tolerance to foreign antigens can be induced in adult life by exposure to antigens under conditions in which specific clones are suppressed. Note that tolerance is not the same as immunological unresponsiveness, since the latter may be very non-specific as in immunodeficiency states.
(18 Nov 1997)
immunologic tolerance Lack of immune response to antigen. Theories of tolerance induction include clonal deletion and clonal anergy. In clonal deletion, the actual clone of cells is eliminated whereas in clonal anergy the cells are present but nonfunctional.
Synonym: immunological tolerance, immunotolerance, nonresponder tolerance.
(05 Mar 2000)
impaired glucose tolerance Blood glucose (sugar) levels higher than normal but not high enough to be called diabetes. People with impaired glucose tolerance may or may not develop diabetes.
Other names (no longer used) for impaired glucose tolerance are borderline, subclinical, chemical, or latent diabetes.
(30 Mar 1998)
individual tolerance Tolerance to a drug that the person has never received before.
(05 Mar 2000)
oral lactose tolerance test A test for lactose deficiency; the plasma glucose response to an oral lactose load is measured as in the (oral) glucose tolerance test.
(05 Mar 2000)
test, glucose tolerance After fasting, a specific amount (100 grams) of glucose is given by mouth, and the blood levels of this sugar are measured every hour. Normally, the blood glucose should return to normal within 2 to 2 1/2 hours. The gtt is considered a classic test of carbohydrate metabolism. It is much used in the diagnosis of diabetes. The gtt depends on a number of factors including the ability of the intestine to absorb glucose, the power of the liver to take up and store glucose, the capacity of the pancreas to produce insulin, and the amount of active insulin.
(12 Dec 1998)
tolerance 1. The ability to endure unusually large doses of a drug or toxin.
2. Acquired drug tolerance, a decreasing response to repeated constant doses of a drug or the need for increasing doses to maintain a constant response.
Origin: L. Tolerantia
(18 Nov 1997)
exercise tolerance The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an exercise test.
(12 Dec 1998)
frustration tolerance The level of an individual's ability to withstand frustration without developing inadequate modes of response, such as "going to pieces" emotionally.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hand organ
    ¼öµ¿½Ä ¿À¸£°£
  • hand organ
    ¼ÕÀ¸·Î µ¹¸®´Â dz±Ý
  • house organ
    »ç³»º¸
  • mouth organ
    Çϸð´ÏÄ«
  • organ
    ¿À¸£°£;ÆÄÀÌÇÁ ¿À¸£°£;(»ý¹°ÀÇ) ±â°ü;(Á¤Ä¡Àû) ±â°ü
  • organ grinder
    ¹è·²¿À¸£°£ ¿¬ÁÖÀÚ
  • pipe organ
    ÆÄÀÌÇÁ ¿À¸£°£
  • positive organ
    ½Ç³» ¿À¸£°£
  • reed organ
    ¸®µå ¿À¸£°£(ÆÄÀÌÇÁ¸¦ »ç¿ëÇÏÁö ¾Ê°í ¸®µå¸¦ »ç¿ëÇÑ ¼ÒÇü ¿À¸£°£)
  • tactile organ
    Ã˰¢ ±â°ü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á